Titre:
  • Incidence and Management of Diarrhea With Adjuvant Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Auteur:Bines, Jose; Procter, Marion; Restuccia, Eleonora; Viale, Giuseppe; Zardavas, Dimitros; Suter, Thomas; Arahmani, Amal; van Dooren, Veerle; Baselga, José; Clark, Emma; Eng-Wong, Jennifer; Gelber, Richard; Piccart-Gebhart, Martine; Mobus, Volker; Azambuja, Evandro
Informations sur la publication:Clinical breast cancer
Statut de publication:Publié, 2020
Sujet CREF:Cancérologie
Mots-clés:Adjuvant
Breast cancer
Diarrhea
HER2
Pertuzumab
Trastuzumab
Note générale:SCOPUS: ar.j
DecretOANoAutActif
Langue:Anglais
Identificateurs:urn:issn:1526-8209
info:doi/10.1016/j.clbc.2019.06.016
info:pii/S1526820919306561
info:scp/85077653685